New York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cryptococcosis Treatment Market Research Report by Treatment, by Distribution - Global Forecast to ...
Ultimately, the goal is to find ways to stop deadly disease caused by Cryptococcus neoformans from developing in humans and animals. But until that time, finding new and better ways to treat already ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Cryptococcosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ...
A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of Cryptococcus. Ultimately, the goal is to find ways to stop deadly disease caused by ...
The Food and Drug Administration (FDA) has granted Orphan Drug designation to APX001 (Amplyx Pharmaceuticals) for the treatment of cryptococcosis. The Food and Drug Administration (FDA) has granted ...
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "Cryptococcosis Treatment Market Research Report by Treatment (Amphotericin B, Fluconazole, and Flucytosine), by Distribution (Hospital Pharmacies, Mail ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results